| | | 占用方与上 | 上市公司核 | 2023 | 年期 | 2023 年上半 | 2023 年上半 | 2023 年上 | 2023 | 年 6 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 非经营性资金占用 | 资金占用方名称 | 市公司的关 | 算的会计科 | 初占用资 | | 年占用累计 | 年占用资金 | 半年偿还累 | | 月末占用 | 占用形成原 | 占用性质 | | | | | | | | 发生金额（不 | 的利息（如 | | | | 因 | | | | | 联关系 | 目 | 金余额 | | | | 计发生金额 | | 资金余额 | | | | | | | | | | 含利息） | 有） | | | | | | | 控股股东、实际控制人及 | | | | | | | | | | | | 非经营性占用 | | 其附属企业 | | | | | | | | | | | | 非经营性占用 | | 小计 | - | - | - | | | | | | | | | - ...

优德精密工业（昆山）股份有限公司（以下简称"公司"）第四届董事会第十一次会议于 2023年8月18日召开，审议通过了《关于全资子公司向银行申请综合授信额度的议案》，为满 足全资子公司昆山德系智能装备有限公司（以下简称"德系智能"）生产经营和业务发展的需 要，同意其向银行申请不超过人民币800万元的综合授信额度，本公司无需担保，根据《公司 章程》的相关规定，本事项在公司董事会决策范围内，无需提交股东大会审议。具体如下： | 银行名称 | 申请授信额度 （单位：万元） | | 授信期限 | | --- | --- | --- | --- | | 中信银行股份有限公司苏州分行 | | 800.00 | 2 年 | 证券代码：300549 证券简称：优德精密 公告编号：2023-047 优德精密工业（昆山）股份有限公司 关于全资子公司向银行申请综合授信额度的公告 本公司及董事会全体成员保证公告的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 以上授信额度由德系智能根据实际资金需求进行借贷使用（包括但不限于流动资金借款、银 行承兑汇票、信用证、保函等），最终授信金额、利率、手续费率和期限以银行审批意见为准 ...

一、使用闲置自有资金进行现金管理的基本情况 1、投资目的 为提高自有资金使用效率，在不影响公司正常经营发展资金需求的情况下，合理利用暂 时闲置自有资金购买保本型理财产品，可以增加资金收益，为公司及股东获取更多的回报。 证券代码：300549 证券简称：优德精密 公告编号：2023-046 优德精密工业（昆山）股份有限公司 关于使用闲置自有资金进行现金管理的公告 本公司及董事会全体成员保证公告的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 优德精密工业（昆山）股份有限公司（以下简称"公司"）于 2023 年 8 月 18 日召开的第 四届董事会第十一次会议、第四届监事会第十次会议审议通过了《关于使用闲置自有资金进 行现金管理的议案》，同意在不影响公司正常经营发展资金需求的情况下，公司拟使用不超过 10,000 万元的闲置自有资金进行现金管理，现将具体情况公告如下： 2、投资额度及期限 公司拟使用不超过10,000万元的暂时闲置自有资金购买不超过12个月的保本型理财产品。 在上述额度及决议有效期内，可循环滚动使用。 3、投资品种 购买投资期限不超过12个月的保本型理财产品（包括但不限于协定存款、结 ...

优德精密工业（昆山）股份有限公司 第四届监事会第十次会议决议公告 本公司及监事会全体成员保证公告的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 优德精密工业（昆山）股份有限公司（以下简称"公司"）第四届监事会第十次会议 于2023年8月8日以电子邮件通知全体监事，并于2023年8月18日以现场会议的方式在公司会议 室召开。 本次会议应到监事3名，实到3名，公司董事会秘书陈海鹰女士列席了本次会议，会议由 监事会主席巩军华女士主持。本次监事会会议的召集、召开和表决程序符合《公司法》等法 律、法规及《公司章程》的相关规定，合法有效。 证券代码：300549 证券简称：优德精密 公告编号：2023-041 表决结果：同意 3 票，反对 0 票，弃权 0 票 3、审议通过《关于使用闲置自有资金进行现金管理的议案》； 监事会认为：本次公司使用闲置自有资金进行现金管理，符合《公司章程》及深圳证券 交易所相关法津、法规和规范性文件的规定。公司在不影响正常经营发展资金需求的情况下， 使用不超过10,000万元暂时闲置自有资金购买期限不超过12个月的保本型理财产品，符合公 司和全体股东的利 ...

证券代码：300549 证券简称：优德精密 公告编号：2023-040 优德精密工业（昆山）股份有限公司 第四届董事会第十一次会议决议公告 本公司及董事会全体成员保证公告的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、优德精密工业（昆山）股份有限公司（以下简称"公司"）本次董事会由公司董事长 曾正雄先生召集，会议通知于 2023 年 8 月 8 日以电子邮件方式发出。 2、本次会议于 2023 年 8 月 18 日在昆山市玉山镇迎宾中路 1123 号公司会议室以现场和 通讯相结合的方式召开。 3、本次会议应出席董事 9 人，实际出席董事 9 人。 4、本次会议由公司董事长曾正雄先生主持，全部监事及高级管理人员列席会议。 5、本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等有关法律、法规 及《公司章程》的有关规定，合法有效。 二、董事会会议审议情况 1、审议通过《关于公司 2023 年半年度报告及其摘要的议案》； 董事会认为：公司《2023 年半年度报告及摘要》的内容符合中国证监会和深圳证券交易 所的相关规定，报告内容真实、准确、完整，不存在虚假记载、误导 ...

证券代码：300549 证券简称：优德精密 优德精密工业（昆山）股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------|----------------------------------|----------------| | | | 编号:2023－001 | | | 分析师会议 | | | | 业绩说明会 | | | 投资者关系活动 | 路演活动 | | | 类别 | | | | | | | | | | | | 参与单位名称及 | 年年度报告网上业绩说明会的投资者 | | | 人员姓名 | | | 时 间 2023 年 5 月 9 日（星期二）15：00－17：00 地 点 江苏省昆山市玉山镇迎宾路 1123 号 董事长：曾正雄 总经理：陈志伟 上市公司出席人 独立董事：杨艳波 财务总监：袁家红 员 董事会秘书：陈海鹰 保荐代表人：章睿鹏 优德精密工业（昆山）股份有限公司（以下简称"公司"、"优德 精密"）于 2023 年 5 月 9 日下午 15:00-17:00 通过全景网投资者关系互 动平台（https://ir.p5w.net/）举办 20 ...

Financial Performance - The company's operating revenue for 2022 was CNY 396,707,346.51, representing a 1.70% increase compared to CNY 390,087,796.42 in 2021[22] - The net profit attributable to shareholders for 2022 was CNY 28,486,285.44, a decrease of 25.87% from CNY 38,425,757.43 in the previous year[22] - The net profit after deducting non-recurring gains and losses was CNY 22,518,470.66, down 28.12% from CNY 31,329,316.40 in 2021[22] - The net cash flow from operating activities increased significantly by 198.05% to CNY 78,324,713.56, compared to CNY 26,278,968.47 in 2021[22] - The total assets at the end of 2022 were CNY 743,066,813.12, a decrease of 2.90% from CNY 765,252,316.13 at the end of 2021[22] - The net assets attributable to shareholders at the end of 2022 were CNY 547,938,447.75, showing a slight increase of 0.30% from CNY 546,284,181.73 in 2021[22] - The basic earnings per share for 2022 were CNY 0.21, down 27.59% from CNY 0.29 in 2021[22] - The weighted average return on equity for 2022 was 5.21%, a decrease from 7.20% in the previous year[22] - Operating profit decreased by 30.51% to CNY 30.38 million, while total profit fell by 29.21% to CNY 30.82 million[51] - The company's operating revenue experienced a slight increase compared to the previous year, but due to higher R&D and financial expenses, operating profit, total profit, and net profit attributable to shareholders decreased[44] Dividends and Profit Distribution - The company plans to distribute a cash dividend of CNY 1.2 per 10 shares, totaling CNY 16,000,000 based on 133,340,000 shares[4] - The total distributable profit for the year was 195,851,680.19 CNY, with cash dividends representing 100% of the profit distribution[158] - For the fiscal year 2022, the proposed cash dividend is 1.20 CNY per 10 shares, amounting to 1,600,080 CNY, pending shareholder approval[159] - The company distributed a cash dividend of 2 CNY per 10 shares, totaling 16,000,800 CNY for the fiscal year 2021[156] Research and Development - The company has a professional R&D team of 95 people, accounting for 12.8% of the total workforce, enhancing its core R&D capabilities[46] - Research and development (R&D) investment reached CNY 23,146,437.15 in 2022, accounting for 5.83% of total revenue, an increase from 5.12% in 2021[67] - The company increased R&D expenses due to market demands, contributing to the decline in profits[51] - Investment in R&D increased by 30%, focusing on innovative technologies and new product development to enhance competitive advantage[185] - The company is investing 50 million in R&D for new technologies aimed at enhancing product efficiency[133] Market and Industry Trends - The industrial automation market in China is projected to reach 281.6 billion yuan in 2022, growing from 253 billion yuan in 2021, reflecting a compound annual growth rate of 12.2% from 2016 to 2021[35] - The automotive industry, which accounts for approximately 30%-40% of the company's main products, saw production and sales of 27.02 million and 26.86 million vehicles respectively in 2022, representing year-on-year growth of 3.4% and 2.1%[33] - The Chinese medical device market is expected to reach 958.2 billion yuan in 2022, with a compound annual growth rate of about 17.5% over the past seven years[36] - The company is focusing on expanding its market presence in both domestic and international markets, particularly in the automotive and medical sectors[53] Risk Management - The company has outlined potential risk factors and countermeasures in its annual report, emphasizing the importance of investor awareness regarding investment risks[4] - The company faces risks from raw material price fluctuations, which account for over 60% of its main business costs, and plans to mitigate this through strategic procurement[101] - The company relies heavily on a single supplier for 35%-45% of its raw materials, which poses a supply risk that it aims to address by developing quality suppliers[102] - The company has implemented risk control measures to reduce the likelihood and extent of accounts receivable losses, aiming to improve capital utilization efficiency[108] Governance and Compliance - The company held three shareholder meetings during the reporting period, passing a total of 11 resolutions, ensuring compliance with governance standards[113] - The board of directors consists of 9 members, including 3 independent directors, and has convened 6 meetings, passing 26 resolutions, reflecting a structured governance approach[114] - The company emphasizes the importance of maintaining independence from its controlling shareholder in terms of business operations, personnel, and financial matters[120] - The company has established an independent financial department with a standardized financial accounting system and independent bank accounts, ensuring no shared accounts with controlling shareholders[126] Employee and Social Responsibility - The total number of employees at the end of the reporting period is 742, with 716 in the parent company and 26 in major subsidiaries[151] - The company provides various employee benefits such as meals, accommodation, annual health check-ups, birthday gifts, gym access, and travel activities[153] - The company has established a comprehensive occupational health management system and conducted regular health check-ups for employees[176] - The company donated RMB 100,000 during the 99 Public Welfare Day event organized by Kunshan City, reflecting its commitment to social responsibility[179] Environmental Initiatives - The company implemented a "green factory" evaluation system and was included in the third batch of Jiangsu Province green factories as of December 2022[173] - The company generated 1.2658 million kWh of solar power in 2022, equivalent to saving 506 tons of standard coal and reducing carbon emissions by 601 tons[174] - A commitment to sustainability initiatives has been made, with a target to reduce carbon emissions by 20% by 2025[186] Future Outlook - The company projects a revenue growth of 10% for the next fiscal year, targeting 1.32 billion in total revenue[133] - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[185] - The company aims to enhance its return capacity and protect the interests of small and medium investors through various measures, including establishing stock price stabilization measures[191]

Financial Performance - The company's operating revenue for Q1 2023 was ¥96,030,809.85, representing a 6.96% increase compared to ¥89,780,416.22 in the same period last year[4] - Net profit attributable to shareholders increased by 32.02% to ¥7,434,960.82 from ¥5,631,558.31 year-on-year[4] - Basic and diluted earnings per share rose by 50.00% to ¥0.06 from ¥0.04 in the same period last year[4] - The company reported a net profit margin improvement, with net profit figures to be detailed in subsequent reports[19] - The net profit for Q1 2023 was CNY 7,434,960.82, representing an increase of 32.4% compared to CNY 5,642,865.85 in Q1 2022[20] - Operating profit for Q1 2023 reached CNY 8,715,392.33, up 31.2% from CNY 6,637,914.84 in the same period last year[20] - Total comprehensive income for Q1 2023 was CNY 7,434,960.82, compared to CNY 5,642,865.85 in the same quarter last year[21] Cash Flow - The net cash flow from operating activities was negative at -¥15,119,628.58, a decline of 355.47% compared to -¥3,319,531.33 in the previous year[4] - Cash flow from operating activities showed a net outflow of CNY -15,119,628.58, worsening from CNY -3,319,531.33 in Q1 2022[22] - The net cash flow from investing activities was positive at ¥3,470.63, a substantial increase compared to -¥404.58 in the same period last year[10] - Investment activities generated a net cash inflow of CNY 34,706,267.37, compared to a net outflow of CNY -4,045,781.14 in the previous year[24] Assets and Liabilities - Total assets decreased by 3.14% to ¥719,708,726.35 from ¥743,066,813.12 at the end of the previous year[4] - Total assets as of March 31, 2023, were RMB 719,708,726.35, down from RMB 743,066,813.12 at the beginning of the year[17] - Total liabilities decreased to RMB 164,233,830.98 from RMB 195,128,365.37, a reduction of approximately 15.8%[17] - The company's equity attributable to shareholders increased to RMB 555,474,895.37 from RMB 547,938,447.75, reflecting a growth of about 1.0%[17] Operational Metrics - Total operating costs for Q1 2023 amounted to RMB 89,328,080.55, up 6.3% from RMB 83,751,347.17 in Q1 2022[19] - Cash and cash equivalents at the end of Q1 2023 were RMB 100,880,309.11, an increase from RMB 79,400,032.65 at the beginning of the year[15] - Accounts receivable decreased to RMB 162,564,116.54 from RMB 169,077,523.14 at the beginning of the year, reflecting a reduction of approximately 3.0%[16] - Inventory decreased to RMB 64,885,068.63 from RMB 79,428,028.41, indicating a decline of about 18.3%[16] - Short-term borrowings increased to RMB 59,637,889.13 from RMB 57,487,420.82, representing a rise of approximately 3.8%[17] Investment and Shareholder Information - The company reported a significant increase in investment income, rising by 626.97% to ¥16.23 from ¥2.23 year-on-year[8] - The total number of ordinary shareholders at the end of the reporting period was 12,058[12] - The company incurred research and development expenses of CNY 4,404,748.98, down from CNY 5,250,946.81 in Q1 2022[20] - Sales expenses increased to CNY 5,758,046.49 from CNY 4,621,370.19 in the previous year, reflecting a rise of 24.6%[20]

出席本次年度业绩说明会的人员有：董事长曾正雄先生、总经理陈志伟先生、财务总监袁 家红女士、董事会秘书陈海鹰女士、独立董事杨艳波女士、保荐代表人章睿鹏先生。（如有特 殊情况，参与人员相应调整。） 证券代码：300549 证券简称：优德精密 公告编号：2023-017 优德精密工业（昆山）股份有限公司 关于举行 2022 年度网上业绩说明会的公告 本公司及董事会全体成员保证公告的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 优德精密工业(昆山)股份有限公司（以下简称"公司"）2022年年度报告及其摘要于2023 年4月28日刊登在中国证监会指定的创业板信息披露网站巨潮资讯网（www.cninfo.com.cn）。 为使广大投资者能够进一步了解公司生产经营情况，公司定于2023年5月9日（星期二） 15:00-17:00举办2022年度网上业绩说明会，本次年度业绩说明会将采用网络远程的方式举行， 投资者可登录全景网"投资者关系互动平台"http://ir.p5w.net参与本次年度业绩说明会。 为充分尊重投资者，提升交流的针对性，现就公司2022年度业绩说明会提前向投资者公开 征集问题，广泛听取投资 ...

证券代码：300549 证券简称：优德精密 优德精密工业（昆山）股份有限公司 投资者关系活动记录表 编号:2017－001 | --- | --- | --- | --- | |----------|----------------|---------------------------------------------------------------------------|----------------------------------------------------------------| | | | ■ | 特定对象调研 □ 分析师会议 | | | | □ | 媒体采访 □ 业绩说明会 | | | | | | | | 投资者关系活动 | □ | 新闻发布会 □ 路演活动 | | 类别 | | □ 现场参观 | | | | | □ | 其他 （请文字说明其他活动内容） | | | 参与单位名称及 | 广发证券：王珂、罗立波、周静 | | | 人员姓名 | | 兴业基金：张希晨 合众资产：贾文磊 东吴证券：倪正洋、邵玉豪 海通证券：杨震 | | | 时 间 | | 2017 年 5 月 2 ...